Ethics Group of Companies participated in iPHEX 2026 at Bharat Mandapam, New Delhi, engaging with pharmaceutical leaders, manufacturers, distributors and healthcare businesses throughout the three-day industry event. Across the event, held in September 2026, the Ethics Group team used the platform to understand evolving business requirements, discuss industry challenges and explore opportunities across the pharmaceutical value chain.
Representing its integrated capabilities across healthcare and supply chain services, Ethics Group of Companies focused its conversations around four key areas: Pharmacy Retail Chain, Nationwide Distribution, Market Entry for Global Brands and Global Sourcing.
The first day of iPHEX 2026 marked the beginning of extensive discussions at the Ethics Group stall, with visitors from across the pharmaceutical and healthcare ecosystem exploring ways to build stronger and more efficient routes from source to market.
The Ethics Group team engaged with manufacturers, distributors and other industry stakeholders to understand their operational requirements and identify potential areas for collaboration. Discussions covered the importance of connected supply chain capabilities, market access and efficient distribution networks in supporting pharmaceutical businesses.
As the event progressed into its second day, conversations at the Ethics Group stall moved beyond introductions and focused increasingly on specific business requirements, operational challenges and potential opportunities.
The team continued discussions around pharmacy retail networks, nationwide distribution capabilities, global brand market entry and sourcing solutions, while gaining insights into the evolving needs of pharmaceutical businesses operating across domestic and international markets.
These interactions provided an opportunity to explore how integrated capabilities can help businesses create more connected and efficient pathways from source to market.
The third and final day brought the three-day participation at iPHEX 2026 to a close. Over the course of the event, the Ethics Group team connected with a diverse range of pharmaceutical and healthcare stakeholders, gaining a deeper understanding of market requirements and emerging business opportunities.
The event also provided a platform to establish new industry connections, exchange perspectives and discuss practical opportunities across different stages of the pharmaceutical value chain.
The Ethics Group of Companies showcased its focus on supporting businesses through integrated solutions spanning pharmacy retail chains, nationwide distribution, global brand market entry and global sourcing.
Participation at iPHEX 2026 reflects Ethics Group’s continued engagement with the pharmaceutical industry and its focus on developing long-term business relationships. The discussions held during the event highlighted the importance of integrated capabilities, market understanding and reliable execution in building efficient healthcare supply chains.
Ethics Group extends its appreciation to everyone who visited Stall 5A-41 & 5A-42 during iPHEX 2026, as well as the organisers, industry partners and stakeholders who contributed to the three days of meaningful engagement.
With the event concluded, the conversations, relationships and opportunities initiated at iPHEX 2026 will continue to support future business discussions and collaborations across the pharmaceutical and healthcare ecosystem.
